| Literature DB >> 32837611 |
Hemant Bherwani1,2, Moorthy Nair3, Kavya Musugu1, Sneha Gautam4, Ankit Gupta1,2, Atya Kapley1,2, Rakesh Kumar1,2.
Abstract
Air pollution (AP) is one of the major causes of health risks as it leads to widespread morbidity and mortality each year. Its environmental impacts include acid rains, reduced visibility, but more importantly and significantly, it affects human health. The price tag of not managing AP is seen in the rise of chronic obstructive pulmonary disease (COPD), cardiovascular disease, and respiratory ailments like asthma and chronic bronchitis. But as the world battles the corona pandemic, COVID-19 lockdown has abruptly halted human activity, leading to a significant reduction in AP levels. The effect of this reduction is captured by reduced cases of morbidity and mortality associated with air pollution. The current study aims to monetarily quantify the decline in health impacts due to reduced AP levels under lockdown scenario, as against business as usual, for four cities-Delhi, London, Paris, and Wuhan. The exposure assessment with respect to pollutants like particulate matter (PM2.5 and PM10), NO2, and SO2 are evaluated. Value of statistical life (VSL), cost of illness (CoI), and per capita income (PCI) for disability-adjusted life years (DALY) are used to monetize the health impacts for the year 2019 and 2020, considering the respective period of COVID-19 lockdown of four cities. The preventive benefits related to reduced AP due to lockdown is evaluated in comparison to economic damage sustained by these four cities. This helps in understanding the magnitude of actual damage and brings out a more holistic picture of the damages related to lockdown. © Springer Nature B.V. 2020.Entities:
Keywords: Air pollution; COVID – 19; Coronavirus; Economy; Externalities; Mortality
Year: 2020 PMID: 32837611 PMCID: PMC7286556 DOI: 10.1007/s11869-020-00845-3
Source DB: PubMed Journal: Air Qual Atmos Health ISSN: 1873-9318 Impact factor: 3.763
Fig. 1Study area and geographical location of cities
Average ambient air quality parameters for cities during lockdown days (31 days) in 2020 and similar period in 2019 (Real-time air quality index, Delhi, London, Paris, Wuhan 2020)
| City | Lockdown period in 2020 | Mean PM2.5 (μg/m3) | Mean PM10 (μg/m3) | Mean NO2 (μg/m3) | Mean SO2 (μg/m3) | ||||
|---|---|---|---|---|---|---|---|---|---|
| 2020 | 2019 | 2020 | 2019 | 2020 | 2019 | 2020 | 2019 | ||
| Delhi | March 22–April 21 | 82.00 | 130.00 | 51.00 | 123.00 | With WHO Limits | With WHO Limits | With WHO Limits | With WHO Limits |
| London | March 24–April 23 | 58.50 | 68.00 | 29.00 | 34.00 | 33.00 | |||
| Paris | March 18–April 17 | 51.60 | 70.00 | 29.00 | 43.00 | 36.00 | |||
| Wuhan | March 1–March 31 | 119.8 | 145.0 | 50.00 | 75.00 | 31.00 | |||
Parameters considered for mortality/morbidity (Maji et al. 2017; Maji et al. 2018)
| Parameters | Mortality/morbidity | Relative risk ( | Baseline incidence ( |
|---|---|---|---|
| PM2.5 | Total mortality | 1.015 | 543.5 |
| Respiratory disease | 1.022 | 550.9 | |
| Cardiovascular disease | 1.013 | 546 | |
| Asthma attack | 1.021 | 940 | |
| Chronic bronchitis | 1.029 | 694 | |
| PM10 | Total mortality | 1.004 | 1013 |
| Cardiovascular mortality | 1.006 | 497 | |
| Respiratory mortality | 1.008 | 66 | |
| COPD morbidity | 1.005 | 101.4 | |
| Respiratory disease | 1.004 | 1260 | |
| Cardiovascular disease | 1.002 | 436 | |
| NO2 | Total mortality | 1.024 | 543.5 |
| Cardiovascular mortality | 1.021 | 497 | |
| Respiratory mortality | 1.037 | 48.4 | |
| COPD morbidity | 1.009 | 101.4 | |
| Respiratory disease | 1.006 | 1260 | |
| Cardiovascular disease | 1.010 | 436 |
VSL for each polluted city
| City | Value of statistical life (VSL) | VSL (2019) in million US dollar | Author (year) |
|---|---|---|---|
| Delhi | INR 44.69 million (2019) | 0.652 | Majumder and Madheswaran ( |
| London | Euro 1.83 million (2015) | 2.140 | Thomas ( |
| Paris | Euro 0.205 million (2004) | 0.317 | Monzón and Guerrero ( |
| Wuhan | RMB 3.01 million (2017) | 0.455 | Qu et al. ( |
Disability-adjusted life years (WHO 2018)
| Health condition | DALY value (per capita) | |||
|---|---|---|---|---|
| Delhi | London | Paris | Wuhan | |
| Respiratory disease (including COPD, bronchitis, asthma) | 0.019 | 0.008 | 0.010 | 0.004 |
| Cardiovascular disease | 0.055 | 0.043 | 0.038 | 0.069 |
Per capita income of each city
| City | Per capita income (PCI) | PCI (2019) in US dollar | Author (year) |
|---|---|---|---|
| Delhi | INR 4,02,000 (2018) | 6064 | PRS ( |
| London | Euro 43,629 (2015) | 52,027 | TUC ( |
| Paris | Euro 52,100 (2017) | 62,243 | European Commission ( |
| Wuhan | RMB 1,35,136 (2018) | 20,044 | CEIC ( |
Cost of illness for morbidity assessment
| Cities | Morbidity illness | Cost of illness as reported (year) | Cost of illness USD (2019) | Author (year) |
|---|---|---|---|---|
| Delhi | COPD | INR 44390 (2005) | 1675 | Koul et al. ( |
| Asthma | USD 637 (2019) | 637 | Ghoshal et al. ( | |
| Respiratory disease | USD 637 (2019) | 637 | Ghoshal et al. ( | |
| Cardiovascular disease | INR 300000 (2018) | 4522 | Apoorva (2018) | |
| London | COPD | GBP 1640 (2006) | 3028 | Starkie et al. ( |
| Asthma | Euro 169 (2010) | 240 | Mukherjee et al. ( | |
| Respiratory disease | GBP 1850 (2014) | 2603 | Burki ( | |
| Cardiovascular disease | GBP 7600 (2015) | 10,492 | Bhatnagar et al. ( | |
| Paris | COPD | Euro 7924 (2015) | 9174 | Bourbeau et al. ( |
| Asthma | Euro 538 (2010) | 663 | Doz et al. ( | |
| Respiratory disease | GBP 1850 (2014) | 2603 | Burki ( | |
| Cardiovascular disease | Euro 4719 (2013) | 5541 | Tuppin et al. ( | |
| Wuhan | COPD | USD 4527 (2019) | 4527 | (Koul et al. |
| Asthma | USD 1590 (2015) | 1721 | (Shan | |
| Respiratory disease | USD 1089 (2016) | 1133 | (Li et al. | |
| Cardiovascular disease | USD 2236 (2012) | 2581 | (Wang et al. |
Economic damage cost due to lockdown in each country of these cities
| City | City GDP (1) B$ (unless otherwise mentioned) | Country GDP (2) B$ (unless otherwise mentioned) | Ratio (3 = 1/2) | Economic loss-country (4) (B$) | City economy loss (B$) (5 = 4 × 3) | Author (year) |
|---|---|---|---|---|---|---|
| Delhi | INR 8.56 billion | INR 231 billion | 00.04 | 00.14 | 05.36 | The Economic Times 2020 ( |
| London | INR 8.56 billion | INR 231 billion | 00.25 | 74.40 | 18.60 | Office of National Statistics ( |
| Paris | 651.0 | 2470 | 00.26 | 60.00 | 15.81 | Institut national de la statistique et des etudes economiqu INSEE ( |
| Wuhan | 00.02 | 13.61 | 0.002 | 320.0 | 00.51 | Trade commissioner service ( |
Quantification of Impacts in terms of number of people affected due to pollutants
| Pollutant | Health condition | City | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Delhi | London | Paris | Wuhan | ||||||
| 2019 | 2020 | 2019 | 2020 | 2019 | 2020 | 2019 | 2020 | ||
| PM2.5 | Total mortality | 14,089 | 9063 | 3195 | 2387 | 3707 | 2396 | 6829 | 5536 |
| Respiratory disease | 19,605 | 12,789 | 4256 | 3451 | 5335 | 3462 | 9467 | 7843 | |
| Cardiovascular disease | 12,511 | 8013 | 2611 | 2095 | 3258 | 2104 | 6071 | 4965 | |
| Chronic bronchitis | 30,620 | 20,218 | 6832 | 5579 | 8587 | 5593 | 14,728 | 12,312 | |
| Asthma | 32,232 | 20,981 | 7489 | 5643 | 8730 | 5661 | 15,569 | 12,282 | |
| PM10 | Total mortality | 6121 | 1172 | 28 | 9 | 40 | 17 | 934 | 249 |
| Cardiovascular mortality | 4035 | 780 | 19 | 6 | 26 | 12 | 621 | 166 | |
| Respiratory mortality | 718 | 141 | 3 | 1 | 5 | 2 | 111 | 30 | |
| COPD morbidity | 692 | 133 | 3 | 1 | 5 | 2 | 106 | 28 | |
| Respiratory disease | 6780 | 1281 | 31 | 10 | 44 | 19 | 1032 | 275 | |
| Cardiovascular disease | 1289 | 243 | 6 | 2 | 8 | 4 | 194 | 51 | |
| NO2 | Total mortality | 0 | 0 | 168 | 0 | 206 | 0 | 106 | 0 |
| Cardiovascular mortality | 0 | 0 | 131 | 0 | 158 | 0 | 78 | 0 | |
| Respiratory mortality | 0 | 0 | 23 | 0 | 28 | 0 | 14 | 0 | |
| COPD morbidity | 0 | 0 | 12 | 0 | 14 | 0 | 7 | 0 | |
| Respiratory disease | 0 | 0 | 98 | 0 | 118 | 0 | 58 | 0 | |
| Cardiovascular disease | 0 | 0 | 54 | 0 | 65 | 0 | 32 | 0 | |
Fig. 2Mortality and morbidity for the study period in 2020 as against 2019
Morbidity valuation for diseases caused by air pollutants
| Health condition | Total morbidity(COI+DALY) valuation in M$ | |||||||
|---|---|---|---|---|---|---|---|---|
| Delhi | London | Paris | Wuhan | |||||
| 2019 | 2020 | 2019 | 2020 | 2019 | 2020 | 2019 | 2020 | |
| Respiratory disease | 14.78 | 9.64 | 12.95 | 10.50 | 17.03 | 11.05 | 11.56 | 9.58 |
| Cardiovascular disease | 60.72 | 38.89 | 33.23 | 26.66 | 25.67 | 16.58 | 24.05 | 19.67 |
| Chronic bronchitis | 54.88 | 36.24 | 23.69 | 19.34 | 52.64 | 34.29 | 67.97 | 56.82 |
| Asthma attack | 24.30 | 15.82 | 05.09 | 03.83 | 10.93 | 07.09 | 28.16 | 22.22 |
| COPD morbidity | 01.24 | 00.24 | 00.01 | 00.00 | 00.05 | 00.02 | 00.49 | 00.13 |
| Respiratory disease | 05.11 | 00.97 | 00.09 | 00.03 | 00.14 | 00.06 | 01.26 | 00.34 |
| Cardiovascular disease | 06.26 | 01.18 | 00.08 | 00.03 | 00.06 | 00.03 | 00.77 | 00.20 |
| COPD morbidity | 00.00 | 00.00 | 00.04 | 00.00 | 00.14 | 00.00 | 00.03 | 00.00 |
| Respiratory disease | 00.00 | 00.00 | 00.30 | 00.00 | 00.38 | 00.00 | 00.07 | 00.00 |
| Cardiovascular disease | 00.00 | 00.00 | 00.42 | 00.00 | 00.51 | 00.00 | 00.13 | 00.00 |
| Total | 167.29 | 102.97 | 75.89 | 60.40 | 107.56 | 69.12 | 134.49 | 108.95 |
Fig. 3Comparative morbidity losses for each city
Mortality damages with respect to pollutants and respective diseases
| Pollutant | Health condition | Total mortality valuation in B$ | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Delhi | London | Paris | Wuhan | ||||||
| 2019 | 2020 | 2019 | 2020 | 2019 | 2020 | 2019 | 2020 | ||
| PM2.5 | Total PM2.5 mortality (1) | 08.94 | 05.75 | 06.66 | 04.97 | 1.04 | 0.67 | 03.11 | 02.52 |
| PM10 | Total PM10 mortality (2) | 03.89 | 00.74 | 00.06 | 00.02 | 0.01 | 0.00 | 00.42 | 00.11 |
| Cardiovascular mortality | 02.56 | 00.50 | 00.04 | 00.01 | 0.01 | 0.00 | 00.28 | 00.08 | |
| Respiratory mortality | 00.46 | 00.09 | 00.01 | 00.00 | 0.00 | 0.00 | 00.05 | 00.01 | |
| NO2 | Total NO2 mortality (3) | 00.00 | 00.00 | 00.35 | 00.00 | 0.06 | 0.00 | 00.05 | 00.00 |
| Cardiovascular mortality | 00.00 | 00.00 | 00.27 | 00.00 | 0.04 | 0.00 | 00.04 | 00.00 | |
| Respiratory mortality | 00.00 | 00.00 | 00.05 | 00.00 | 0.01 | 0.00 | 00.01 | 00.00 | |
| Total mortality (1 + 2 + 3) | 12.83 | 06.50 | 07.07 | 04.99 | 1.10 | 0.67 | 03.58 | 02.63 | |
Fig. 4Mortality damages for air pollutants for 2019 and 2020
Consolidated results in comparison to economic damage for cities
| City | Days (a) | 2019 AP damage (B$) (1) | 2020 AP damage (B$) (2) | Prevention due to lockdown (B$) (3 = 1–2) | Percentage reduction in 2020 (%) (100 × 3/1) | B$ prevented/day (3/a) | Economic damage due to lockdown (B$) (4) | AP damage prevented per unit economic damage (5 = 3/(−4)) |
|---|---|---|---|---|---|---|---|---|
| Delhi | 31 | 13.00 | 06.60 | 06.40 | 49% | 00.21 | − 05.36 | 01.19 |
| London | 31 | 07.14 | 05.05 | 02.09 | 29% | 00.07 | − 18.60 | 00.11 |
| Paris | 31 | 01.21 | 00.74 | 00.47 | 39% | 00.02 | − 15.81 | 00.03 |
| Wuhan | 31 | 03.71 | 02.74 | 00.97 | 26% | 00.03 | − 00.53 | 01.85 |
Fig. 5AP damage prevented due to lockdown in comparison to economic damage